21 CFR §516.14
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
All correspondence relating to a request for designation of a MUMS drug must be addressed to the Director of the Office of Minor Use and Minor Species Animal Drug Development. Submissions not including all elements specified in § 516.20 will be returned to the sponsor without review.